evoleen Revenue and Competitors
Employee Data
- evoleen has 38 Employees.
- evoleen grew their employee count by 46% last year.
evoleen's People
Name | Title | Email/Phone |
---|
evoleen Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | N/A | 29 | 38% | N/A | N/A |
#2 | N/A | 55 | 31% | N/A | N/A |
#3 | N/A | 29 | 53% | N/A | N/A |
#4 | N/A | 38 | 46% | N/A | N/A |
#5 | N/A | 33 | 38% | N/A | N/A |
#6 | N/A | 39 | 26% | N/A | N/A |
#7 | N/A | 38 | 46% | N/A | N/A |
#8 | N/A | 30 | 58% | N/A | N/A |
#9 | N/A | 98 | 20% | N/A | N/A |
#10 | N/A | 77 | 22% | N/A | N/A |
What Is evoleen?
Evoleen www.evoleen.com is a DISRUPTIVE COMPANY BUILDER that supports global pharmaceutical and medtech enterprises to build, accelerate and enhance their digital health business. With our unique co-creation approach, we offer and share our knowledge in all relevant fields to designing and developing businesses with digital health solutions & smart medical devices. We cover all competencies of customer insight generation, solution ideation, R&D, rapid prototyping, Quality Managment & Regulatory Affairs, ICT and operations. United in a dedicated co-investment startup, our entrepreneurs design and deliver the specified projects within cost and time frame and transfer it as a whole to our partners. \n\nMoreover, our ONE-STOP-SHOP FOR HEALTH START-UPS offers technology development, quality & regulatory consulting and strategic distribution collaborations for our own and any health-start-up in the world that wants to build on the expertise of a HealthTech expert who perfectly understands the start-up world.
keywords:N/AN/A
Total Funding
38
Number of Employees
N/A
Revenue (est)
46%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $4.4M | 38 | N/A | N/A |
#2 | $7.6M | 38 | 6% | N/A |
#3 | $4M | 38 | -40% | $17.5M |
#4 | $6.6M | 39 | 5% | N/A |
#5 | N/A | 39 | 30% | N/A |